Sectioning and extensively examining the fimbriated end (SEE‐FIM) of the fallopian tube in routine practices, is it worth the effort?
- 2 December 2018
- journal article
- research article
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 45 (3) , 665-670
Abstract
Aim: To determine the prevalence of fallopian tube high‐grade serous carcinoma (HGSC) and to analyze the benefit of the sectioning and extensively examining the fimbriated end (SEE‐FIM) protocol.Methods: Fallopian tubes from 450 patients with risk‐reducing salpingo‐oophorectomy, or tumor of the ovary, endometrium, fallopian tube or peritoneum were examined using the SEE‐FIM protocol. Microscopic tubal pathology and the number of paraffin blocks used were evaluated. Immunostaining for p53 was performed to confirm TP53 mutation. Cost effectiveness was determined by equation of incremental cost‐effectiveness ratio.Results: Tubal HGSC were detected in 25 out of 70 cases of pelvic extrauterine HGSC, in 1 case of endometrioid carcinoma, and 4 cases of uterine serous carcinoma out of 250 cases of endometrial neoplasm. The mean number of tissue blocks per case was 6. The incremental cost for detecting one case of coexisting fallopian tube HGSC in the study population was 94 Thai baht/3 USD per case.Conclusion: The SEE‐FIM protocol facilitates identification of lesions that are not distinguishable by classical sampling protocol, and this results in more accurate tumor staging and a better understanding of the carcinogenesis. The benefit of the SEE‐FIM protocol was demonstrated, especially in cases at high risk for coexisting fallopian tube carcinoma.Keywords
Funding Information
- Siriraj Research Development Fund
This publication has 26 references indexed in Scilit:
- Frequency of Serous Tubal Intraepithelial Carcinoma in Various Gynecologic MalignanciesInternational Journal of Gynecological Pathology, 2012
- The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying TheoryAmerican Journal of Surgical Pathology, 2010
- Tubal and ovarian pathways to pelvic epithelial cancer: a pathological perspectiveHistopathology, 2009
- Intercepting early pelvic serous carcinoma by routine pathological examination of the fimbriaLaboratory Investigation, 2009
- Intercepting pelvic cancer in the distal fallopian tube: Theories and realitiesMolecular Oncology, 2009
- Serous Tubal Intraepithelial Carcinoma: Its Potential Role in Primary Peritoneal Serous Carcinoma and Serous Cancer PreventionJournal of Clinical Oncology, 2008
- Primary Fallopian Tube Malignancies in BRCA-Positive Women Undergoing Surgery for Ovarian Cancer Risk ReductionJournal of Clinical Oncology, 2007
- The distal fallopian tube: a new model for pelvic serous carcinogenesisCurrent Opinion in Obstetrics and Gynecology, 2007
- BRCA-Mutation–Associated Fallopian Tube CarcinomaObstetrics & Gynecology, 2005
- Occult Carcinoma in Prophylactic Oophorectomy SpecimensAmerican Journal of Surgical Pathology, 2001